Timing of antiretroviral therapy for HIV-1 infection and tuberculosis DV Havlir, MA Kendall, P Ive, J Kumwenda, S Swindells, SS Qasba, ... New England Journal of Medicine 365 (16), 1482-1491, 2011 | 732 | 2011 |
Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection T Kelesidis, MA Kendall, OO Yang, HN Hodis, JS Currier The Journal of infectious diseases 206 (10), 1558-1567, 2012 | 250 | 2012 |
Carotid artery intima–media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure JS Currier, MA Kendall, R Zackin, WK Henry, B Alston-Smith, FJ Torriani, ... Aids 19 (9), 927-933, 2005 | 238 | 2005 |
Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV GA McComsey, MA Kendall, P Tebas, S Swindells, E Hogg, ... Aids 21 (18), 2473-2482, 2007 | 183 | 2007 |
Progression of carotid artery intima–media thickening in HIV-infected and uninfected adults JS Currier, MA Kendall, WK Henry, B Alston-Smith, FJ Torriani, P Tebas, ... Aids 21 (9), 1137-1145, 2007 | 168 | 2007 |
Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers MJ Glesby, JA Aberg, MA Kendall, CJ Fichtenbaum, R Hafner, S Hall, ... Clinical Pharmacology & Therapeutics 78 (2), 143-153, 2005 | 114 | 2005 |
Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: a randomized trial M Maiman, DH Watts, J Andersen, P Clax, M Merino, MA Kendall Obstetrics & Gynecology 94 (6), 954-961, 1999 | 107 | 1999 |
Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group … A Erice, C Tierney, M Hirsch, AM Caliendo, A Weinberg, MA Kendall, ... Clinical infectious diseases 37 (4), 567-578, 2003 | 104 | 2003 |
Evaluation of Xpert MTB/RIF versus AFB smear and culture to identify pulmonary tuberculosis in patients with suspected tuberculosis from low and higher prevalence settings AF Luetkemeyer, C Firnhaber, MA Kendall, X Wu, GH Mazurek, ... Clinical infectious diseases 62 (9), 1081-1088, 2016 | 101 | 2016 |
Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV–TB programs AF Luetkemeyer, MA Kendall, M Nyirenda, X Wu, P Ive, CA Benson, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 65 (4), 423-428, 2014 | 92 | 2014 |
Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030 DA Wohl, MA Kendall, J Andersen, C Crumpacker, SA Spector, ... HIV clinical trials 10 (3), 143-152, 2009 | 82 | 2009 |
Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy EM Stringer, MA Kendall, S Lockman, TB Campbell, K Nielsen-Saines, ... PloS one 13 (7), e0199555, 2018 | 77 | 2018 |
Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir DW Haas, SL Koletar, L Laughlin, MA Kendall, C Suckow, JG Gerber, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 50 (3), 290-293, 2009 | 77 | 2009 |
Fractures after antiretroviral initiation MT Yin, MA Kendall, X Wu, K Tassiopoulos, M Hochberg, JS Huang, ... Aids 26 (17), 2175-2184, 2012 | 76 | 2012 |
Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals … AF Luetkemeyer, MA Kendall, X Wu, MC Lourenço, U Jentsch, ... Journal of clinical microbiology 52 (4), 1052-1059, 2014 | 64 | 2014 |
The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy DA Wohl, MA Kendall, S Owens, G Holland, M Nokta, SA Spector, ... HIV Clinical Trials 6 (3), 136-146, 2005 | 55 | 2005 |
International randomized trial of immediate vs early ART in HIV+ patients treated for TB: ACTG 5221 STRIDE Study D Havlir, P Ive, M Kendall, A Luetkemeyer, S Swindells, J Kumwenda, ... 18th Conference on Retroviruses and Opportunistic Infections 27, 2011 | 54 | 2011 |
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily EP Acosta, MA Kendall, JG Gerber, B Alston-Smith, SL Koletar, AR Zolopa, ... Antimicrobial agents and chemotherapy 51 (9), 3104-3110, 2007 | 51 | 2007 |
Cytomegalovirus-Specific Immunity and Protection against Viremia and Disease in HN-Infected Patients in the Era of Highly Active Antiretroviral Therapy A Weinberg, C Tierney, MA Kendall, RJ Bosch, J Patterson-Bartlett, ... Journal of Infectious Diseases 193 (4), 488-493, 2006 | 44 | 2006 |
A pilot metabolomics study of tuberculosis immune reconstitution inflammatory syndrome CAM Silva, B Graham, K Webb, LV Ashton, M Harton, AF Luetkemeyer, ... International Journal of Infectious Diseases 84, 30-38, 2019 | 31 | 2019 |